Not applicableUnknownNCT02395198What this trial is testingEpidemiology of Hepatitis C Virus Infection Among Opioid Substituted PatientsWho this might be right forHepatitis C Prof. Dr. med. Jens Reimer 2,467
Not applicableEnded earlyNCT04499651What this trial is testingTesting of a Navigation Intervention for Hepatitis C and HIVWho this might be right forHIV (Human Immunodeficiency Virus)Hepatitis C University of California, Los Angeles 1
Testing effectiveness (Phase 2)Study completedNCT01265511What this trial is testingStudy of SCY-635, Pegasys and Copegus in Hepatitis CWho this might be right forHepatitis C Infection Scynexis, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT02994056What this trial is testingEvaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C CirrhosisWho this might be right forHepatitis C Virus Infection Gilead Sciences 32
Not applicableStudy completedNCT00723931What this trial is testingPegIntron Injection Surveillance Plan (Study P04123)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 1,267
Post-approval studies (Phase 4)WithdrawnNCT00782301What this trial is testingMaraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsWho this might be right forHepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic ViiV Healthcare
Large-scale testing (Phase 3)Study completedNCT01851330What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)Who this might be right forChronic Hepatitis C Virus Gilead Sciences 647
Very early researchActive Not RecruitingNCT03112044What this trial is testingLung Transplant HCV, Pilot StudyWho this might be right forLung Transplant InfectionHepatitis C University Health Network, Toronto 26
Large-scale testing (Phase 3)Study completedNCT00224705What this trial is testingThe MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic FailureWho this might be right forHepatitis Assistance Publique - Hôpitaux de Paris 110
Not applicableNot Yet RecruitingNCT07525401What this trial is testingComparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral HepatitisWho this might be right forHepatitis AHepatitis E Virus Infection Combined Military Hospital, Pakistan 88
Post-approval studies (Phase 4)UnknownNCT04056728What this trial is testingA Phase IV Study to Assess the Safety of EupentaTM InjWho this might be right forHepatitis BDiphtheriaHaemophilus Influenzae Type B Infection+2 more LG Chem 3,000
Large-scale testing (Phase 3)Study completedNCT00637195What this trial is testingImmunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)Who this might be right forInfections, PapillomavirusPapillomavirus Vaccines GlaxoSmithKline 152
Not applicableUnknownNCT03827772What this trial is testingFecal Microbiota Transplantation in Severe Alcoholic Hepatitis- Assessment of Impact on Prognosis and Short-term OutcomeWho this might be right forSevere Alcoholic Hepatitis Post Graduate Institute of Medical Education and Research, Chandigarh 40
Post-approval studies (Phase 4)Study completedNCT01841775What this trial is testingInterferon α 2b Pharmacovigilance StudyWho this might be right forHepatitis C, Chronic The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 85
Large-scale testing (Phase 3)Study completedNCT01369212What this trial is testingCombination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis BWho this might be right forHepatitis B National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 201
Early research (Phase 1)Study completedNCT01525628What this trial is testingDrug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsWho this might be right forHepatitis C, Chronic Boehringer Ingelheim 72
Early research (Phase 1)Study completedNCT02063607What this trial is testingThe Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C PatientsWho this might be right forHepatitis C Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Not applicableStudy completedNCT03341871What this trial is testingGlecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6Who this might be right forHepatitis C Virus (HCV) AbbVie 1,095
Testing effectiveness (Phase 2)Study completedNCT00863239What this trial is testingPhase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCVWho this might be right forHepatitis C, Chronic Biolex Therapeutics, Inc. 116
Large-scale testing (Phase 3)Study completedNCT01917357What this trial is testingA Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and UnijectWho this might be right forDiphtheriaPertussisTetanus+2 more Crucell Holland BV 400